NasdaqCM - Delayed Quote USD

Aclarion, Inc. (ACONW)

0.0500 -0.0110 (-18.03%)
At close: April 26 at 4:00 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Jeffrey John Thramann M.D. Executive Chairman 300k -- 1965
Mr. John Lorbiecki Chief Financial Officer 225k -- 1964
Mr. Ryan Bond Chief Strategy Officer 200k -- 1973
Mr. Brent Ness CEO, President & Director 418.75k -- 1967

Aclarion, Inc.

8181 Arista Place
Suite 100
Broomfield, CO 80021
United States
833 275 2266 https://www.aclarion.com
Sector: 
Healthcare
Full Time Employees: 
4

Description

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Corporate Governance

Aclarion, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers